Agencies review aliskiren after termination of multinational trial News item 11 January 2013 Pages: 1 - 1
Health Canada is warning Canadians of a significant labelling error in the French dosing News item 11 January 2013 Pages: 3 - 3
Clinicians are reminded by Pfizer of the correct route of administration for Hemabate sterile solution News item 11 January 2013 Pages: 3 - 3
The EMA is recommending the authorisation of lacosamide [Vimpat] syrup for patients with epilepsy News item 11 January 2013 Pages: 3 - 3
The US FDA has approved a single shared REMS* for the transmucosal immediate-release fentanyl Media release 11 January 2013 Pages: 3 - 3
Extended nevirapine prophylaxis ‘safe’ in breast-fed infants Clinical study 11 January 2013 Pages: 4 - 4
The public is being warned by the US FDA about a potential risk associated with opioid analgesic News item 11 January 2013 Pages: 4 - 4
The EMA’s Pharmacovigilance Working Party (PhVWP) has recommended updates to the product labelling of atomoxetine, News item 11 January 2013 Pages: 4 - 4
A new law adopted in France late last year establishes a new agency for drug safety, the ANSM* News item 11 January 2013 Pages: 4 - 4
Antithymocyte globulin/mycophenolic acid/prednisone/tacrolimus Case report 11 January 2013 Pages: 9 - 9
